3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessation

Bioorganic & Medicinal Chemistry Letters
2005.0

Abstract

3,5-Bicyclic aryl piperidines are a new class of high-affinity alpha4beta2 nicotinic receptor agents. We have sought nicotinic receptor partial agonists of the alpha4beta2 nicotinic acetylcholine receptor for smoking cessation, and a number of compounds fulfill potency, selectivity, and efficacy requirements in vitro. In vivo, selected agents demonstrate potent partial agonist efficacy on the mesolimbic dopamine system, a key measure of therapeutic potential for smoking cessation.

Knowledge Graph

Similar Paper

3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessation
Bioorganic & Medicinal Chemistry Letters 2005.0
Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Journal of Medicinal Chemistry 2005.0
In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation: Carbon analogs of (−)-cytisine
Bioorganic & Medicinal Chemistry Letters 2005.0
7-Azaindole derivatives as potential partial nicotinic agonists
Bioorganic & Medicinal Chemistry Letters 2008.0
A novel series of [3.2.1] azabicyclic biaryl ethers as α3β4 and α6/4β4 nicotinic receptor agonists
Bioorganic & Medicinal Chemistry Letters 2010.0
N,N-Disubstituted piperazines: synthesis and affinities at α4β2∗ and α7∗ neuronal nicotinic acetylcholine receptors
Bioorganic & Medicinal Chemistry Letters 2003.0
Structure–Activity Studies of 7-Heteroaryl-3-azabicyclo[3.3.1]non-6-enes: A Novel Class of Highly Potent Nicotinic Receptor Ligands
Journal of Medicinal Chemistry 2012.0
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3* Nicotinic Receptors
Journal of Medicinal Chemistry 2019.0
Identification and synthesis of novel alkaloids from the root system of Nicotiana tabacum: Affinity for neuronal nicotinic acetylcholine receptors
Life Sciences 2005.0
Novel α3β4 Nicotinic Acetylcholine Receptor-Selective Ligands. Discovery, Structure−Activity Studies, and Pharmacological Evaluation
Journal of Medicinal Chemistry 2010.0